Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?

Med Pediatr Oncol. 2002 Jul;39(1):63-5. doi: 10.1002/mpo.10047.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Asparaginase / administration & dosage
  • Chromosomes, Human, Pair 11 / genetics*
  • Chromosomes, Human, Pair 4 / genetics*
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Cytogenetic Analysis
  • DNA Primers / chemistry
  • Daunorubicin / administration & dosage
  • Female
  • Humans
  • Infant
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Prednisone / administration & dosage
  • Translocation, Genetic*
  • Vincristine / administration & dosage

Substances

  • DNA Primers
  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Mercaptopurine
  • Asparaginase
  • Prednisone
  • Methotrexate
  • Daunorubicin

Supplementary concepts

  • AIEOP acute lymphoblastic leukemia protocol